跳至主要内容
临床试验/NCT02899910
NCT02899910已完成2 期

Nutrition and Exercise Study to Understand Metabolic Syndrome

Vanderbilt University Medical Center0 个研究点目标入组 67 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
67
主要终点
Change in insulin resistance

研究概览

简要总结

The purpose of this study is to measure the metabolic and behavioral effects of a 12-week yoga program coupled to health education (HED) compared to HED alone.

详细描述

The purpose of this study is to measure the metabolic and behavioral effects of a 12-week yoga program coupled to health education (HED) compared to HED alone. In a randomized clinical trial of 90 patients (45 patients per arm), investigators will measure the effects of the two interventions on IR, HTN, dysplidemia, and body composition (See Figure 1. Study Diagram). Subjects will be scheduled for outcome assessment at baseline, 12 weeks, and 24 weeks. In addition, investigators will collect data at baseline and 12 weeks on self-efficacy, stress, mindfulness, and mood. As a sub-study to the randomized controlled trial, investigators will measure the aerobic intensity of the yoga to estimate the dose of physical exercise provided by the yoga (n=10).

Subjects willing and eligible to participate in the RCT will receive written consent. Consented subjects will be randomized to either 12 weeks of yoga with HED versus HED alone. Subjects randomized to yoga will receive 30 to 45 minutes of weekly yoga instruction, followed by 30 to 45 minutes of HED. Subjects will receive written instructions for home yoga practice and lifestyle changes based on HED. Subjects randomized to HED alone will receive a weekly standardized HED curriculum which will be attention and time matched to the yoga with HED arm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elevated waist circumference (Men greater than 102cm; women greater than 88cm)
  • Impaired fasting glucose (100-125 mg/dl)
  • Elevated blood pressure (systolic ≥130 and/or diastolic ≥ 85)
  • Dyslipidemia (triglycerides ≥150 and/or HDL≤ 40 for men; 50 for women)
  • English speaking

排除标准

  • Currently taking blood pressure medications, oral diabetic medication or insulin, or lipid medication
  • Systolic blood pressure ≥160 and/or diastolic ≥100
  • Unstable cardiac disease e.g. angina, life threatening arrhythmia
  • Lung disease requiring oxygen supplementation at rest or with ambulation
  • History of dementia or cognitive impairment
  • Uncontrolled psychiatric disorders, such as major depression or psychosis
  • Current participation in a mind-body practice/program

结局指标

主要结局

Change in insulin resistance

时间窗: Baseline, 12 weeks, and 24 weeks

次要结局

  • Change in quality of life(Baseline and 12 weeks)
  • Change in dyslipidemia(Baseline, 12, and 24 weeks)
  • Change in affect measured through questionnaire Profile of Mood States(Baseline and 12 weeks)
  • Change in hypertension(Baseline, 12, and 24 weeks)
  • Change in stress(Baseline and 12 weeks)
  • Change in mindfulness(Baseline and 12 weeks)
  • Change in self-efficacy(Baseline and 12 weeks)
  • Change in diet(Baseline, 12, and 24 weeks)
  • Change in body composition(Baseline, 12, and 24 weeks)
  • Change in physical activity measured with accelerometers(Baseline, 12, and 24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gurjeet Birdee

Principle Investigator

Vanderbilt University Medical Center

相似试验